Antitumor effect of local cancer immunotherapy treatment in various tumor models. Antitumor effect of local cancer immunotherapy treatment in various tumor.

Slides:

Advertisements

Similar presentations

Identification of combination treatment–responsive dysfunctional tumor-infiltrating CD8+ T cell population. Identification of combination treatment–responsive.

Advertisements

Soft robotic device applied to the RV in a pressure overload model of RHF. Soft robotic device applied to the RV in a pressure overload model of RHF. (A.

Immunologic responses after the MN-mediated cancer immunotherapy.

Cytotoxicity of MSP samples to normal and cancer cell lines.

Specific depletion of TFH and LCMV-specific CD4 T cells.

TPAD controller performance for three force components.

NFATc2-deficient mice do not eliminate skin C. albicans infections.

Antitumor effect of local cancer immunotherapy treatment toward distant B16F10 tumors. Antitumor effect of local cancer immunotherapy treatment toward.

Specific depletion of CD4-DTR–derived CD4 T cells.

Three different types of transfer functions with a codomain of [0,1].

TPAD training protocol.

Ex vivo testing of the soft robotic devices.

Human PBMC-derived MERS-CoV–specific T cells are multifunctional.

Deficiency in myeloid-resident NRP1 affects systemic metabolism.

Platelets are required for hFcγRIIA-induced anaphylaxis.

Time courses of SSc-PAH signatures.

Comparison of repertoire distributions to baseline.

Tukey boxplots overlaid on data points from objective and subjective measures, displaying results from study 1. Tukey boxplots overlaid on data points.

Tfr cells robustly secrete IL-10 after acute viral infection.

Tfr cell–derived IL-10 is important for B cell differentiation and the GC response. Tfr cell–derived IL-10 is important for B cell differentiation and.

Characterization of the light-responsive transdermal MNs.

T-bethi MP cells produce IFN-γ in response to IL-12.

On-demand, NIR light–triggered hyperthermia termination switch for RBC microswimmers. On-demand, NIR light–triggered hyperthermia termination switch for.

BAP1 deficiency results in thymic atrophy and loss of thymocyte populations. BAP1 deficiency results in thymic atrophy and loss of thymocyte populations.

Immune cell recruitment after the NIR-boosted and MN-mediated cancer immunotherapy. Immune cell recruitment after the NIR-boosted and MN-mediated cancer.

CXCR5+/+ TFH cells are essential for the generation of LCMV-neutralizing antibodies and clearance of a persistent LCMV infection. CXCR5+/+ TFH cells are.

Cell viability tests. Cell viability tests. SEM images of (A) MC3T3-E1 cells and (B) MSCs on days 1, 3, and 5 of culture. (C) Survival rates of MC3T3-E1.

Administration of necroptosis-targeting AAVs in conjunction within vivo promotes durable tumor clearance. Administration of necroptosis-targeting AAVs.

Tumor control by necroptotic cells requires BATF3+cDC1 and CD8+leukocytes. Tumor control by necroptotic cells requires BATF3+cDC1 and CD8+leukocytes. (A)

Fig. 3 M7824 inhibits tumor growth and metastasis and provides long-term antitumor immunity. M7824 inhibits tumor growth and metastasis and provides long-term.

Evaluation of multidonor class Ig sequences obtained from H5N1 and H7N9 vaccinated donors. Evaluation of multidonor class Ig sequences obtained from H5N1.

Microrobots with different cell-carrying capacities under different grid lengths (lg) and burr lengths (lb). Microrobots with different cell-carrying capacities.

Platelet-released serotonin contributes to hypothermia in mice undergoing HA-hIgG–dependent anaphylaxis. Platelet-released serotonin contributes to hypothermia.

Genetic EGFR ablation in K-RAS–mutated lung AC reduces tumor growth

Vaccine MN confer protective innate and adaptive immunity.

Innate immune and fibrinolytic systems cooperate also during bacterial infections. Innate immune and fibrinolytic systems cooperate also during bacterial.

Soft robotic device applied to the RV in a pressure overload model of RHF. Soft robotic device applied to the RV in a pressure overload model of RHF. (A.

Steady-state performance of the soft robotic device in LHF models.

Fig. 3 NK cells are enriched in ICB-sensitive tumors in mouse models and patients and are required for response. NK cells are enriched in ICB-sensitive.

Fig. 1. CAR4 and CAR8 cells demonstrate in vitro and in vivo antileukemic efficacy. CAR4 and CAR8 cells demonstrate in vitro and in vivo antileukemic efficacy.

Fig. 4 Rational therapeutic modulation of the tumor microenvironment sensitizes tumors to ICB. Rational therapeutic modulation of the tumor microenvironment.

Fig. 2 In situ vaccination of CpG in combination with anti-OX40 antibody cures established local and distant tumors. In situ vaccination of CpG in combination.

Tfr cells respond better to immunization with self-antigens than with foreign antigens. Tfr cells respond better to immunization with self-antigens than.

Type I and III IFNR expression on hematopoietic cells is required for protection against IA. Type I and III IFNR expression on hematopoietic cells is required.

Results of a representative participant with multiple training sessions. Results of a representative participant with multiple training sessions. Average.

In vivo assessment of synergistic activity of MV-CEA and RT in a U87 s

Galloping-like gait with the design of a two-legged robot.

Fig. 3 Load dependence of friction force and corresponding COF.

AEGIS autonomous targeting process.

Antitumor activity of KM100+5 μmol/L MTX treatment in the presence or absence of CD8+ T cells in BALB-neuT mice bearing subcutaneous tumors of TUBO cells.

Fig. 2 Extended local release of agonists of innate immunity prevents tumor recurrence and eliminates distal metastases. Extended local release of agonists.

Fig. 3 Local Maraba treatment of TNBC tumors provides long-term systemic protection. Local Maraba treatment of TNBC tumors provides long-term systemic.

Fig. 3 Production of protein and Fe(II) at the end of growth correlated with increasing concentrations of ferrihydrite in the media that contained 0.2.

PD and efficacy of AZD4785 in KRAS mutant lung cancer xenograft models

Pharmacological targeting of CDs promotes response to KRASG12C inhibition in vivo. Pharmacological targeting of CDs promotes response to KRASG12C inhibition.

Tumor protection induced by therapeutic PLG vaccination in combination with blockade antibodies. Tumor protection induced by therapeutic PLG vaccination.

In vivo prophylactic and therapeutic efficacy of C12G6 in mice

Fig. 6 The combined therapeutic efficacy of N-pepABS and low dose of Dox on MDA-MB-231 xenografts. The combined therapeutic efficacy of N-pepABS and low.

IL-33 is not critical for initiation of allergic airways disease phenotype. IL-33 is not critical for initiation of allergic airways disease phenotype.

Fig. 3 Comparisons of NDVI trends over the globally vegetated areas from 1982 to Comparisons of NDVI trends over the globally vegetated areas from.

Fig. 6. Combinatorial VCPI and OV M1 treatment is efficacious in vivo and ex vivo. Combinatorial VCPI and OV M1 treatment is efficacious in vivo and ex.

Fig. 7 Differences in the tumor microenvironment between transplant and transgenic BRAFV600E-driven melanoma models may underlie refractoriness of iBIP2.

Fig. 3 Superiority of BAFF-R versus CD19-CAR T cells in a Burkitt lymphoma model is not due to greater tumor antigen density. Superiority of BAFF-R versus.

Acute circadian disruption alters ILC3 cytokine secretion.

REV-ERBα deficiency reduces frequency and number of NKp46+ ILC3s.

Meningeal γδ T cell homeostasis is independent of inflammatory signals

PD and efficacy of AZD4785 in a KRAS wild-type lung cancer PDX model

In response to allergen, T cells and ILCs are equally important sources of IL-13. In response to allergen, T cells and ILCs are equally important sources.

Fig. 5 Controlled tumor growth inhibition study of the self-assembled nanostructures. Controlled tumor growth inhibition study of the self-assembled nanostructures.

Fig. 2 Imaging blood vessel before and after closure.

Presentation transcript:

Antitumor effect of local cancer immunotherapy treatment in various tumor models. Antitumor effect of local cancer immunotherapy treatment in various tumor models. (A) Average tumor growth and Kaplan-Meier survival rate of vaccinated C57BL/6J mice after BP tumor cell challenge. Mice were pretreated with blank MN (blank), MN loaded with BP tumor lysate and melanin (MN), or loaded MN combined with NIR irradiation (MN + NIR). (B) Average tumor growth and Kaplan-Meier survival rate of vaccinated BALB/cJ mice after 4T1 tumor cell challenge. Mice were pretreated with blank MN, MN loaded with 4T1 tumor lysate and melanin, or loaded MN combined with NIR irradiation. (C) Average tumor growth and Kaplan-Meier survival rate of C57BL/6J mice bearing established BP tumors. Mice were treated with blank MN, MN loaded with BP tumor lysate and melanin, or loaded MN combined with NIR irradiation. (D) Average tumor growth and Kaplan-Meier survival rate of BALB/cJ mice bearing established 4T1 tumors. Mice were treated with blank MN, MN loaded with 4T1 tumor lysate and melanin, or loaded MN combined with NIR irradiation. Data points represent mean ± SD (n = 8). Error bars indicate SD. Statistical significance was calculated by Student’s t test and log-rank test (*P < 0.05; **P < 0.01; ***P < 0.001). Yanqi Ye et al. Sci. Immunol. 2017;2:eaan5692 Copyright © 2017 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works